ALDX
Aldeyra Therapeutics Inc

8,201
Mkt Cap
$334.51M
Volume
159,430.00
52W High
$7.20
52W Low
$1.14
PE Ratio
-7.70
ALDX Fundamentals
Price
$5.64
Prev Close
$5.56
Open
$5.50
50D MA
$4.93
Beta
2.77
Avg. Volume
875,589.45
EPS (Annual)
-$0.9389
P/B
6.79
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Wall Street Analysts Predict a 65.75% Upside in Aldeyra Therapeutics (ALDX): Here's What You Should Know
The consensus price target hints at a 65.8% upside potential for Aldeyra Therapeutics (ALDX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·7d ago
News Placeholder
More News
News Placeholder
Are Medical Stocks Lagging Aldeyra Therapeutics (ALDX) This Year?
Here is how Aldeyra Therapeutics, Inc. (ALDX) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
Zacks·7d ago
News Placeholder
PFG Investments LLC Reduces Stock Position in Aldeyra Therapeutics, Inc. $ALDX
PFG Investments LLC cut its stake in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX - Free Report) by 74.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange...
MarketBeat·12d ago
News Placeholder
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Short Interest Update
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX - Get Free Report) saw a significant decline in short interest during the month of December. As of December 31st, there was short interest totaling 4,951,552...
MarketBeat·23d ago
News Placeholder
Aldeyra Therapeutics (NASDAQ:ALDX) Shares Cross Above Fifty Day Moving Average - Time to Sell?
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Crosses Above 50-Day Moving Average - Here's Why...
MarketBeat·1mo ago
News Placeholder
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Crosses Above Fifty Day Moving Average - Should You Sell?
Aldeyra Therapeutics (NASDAQ:ALDX) Share Price Crosses Above 50 Day Moving Average - What's Next...
MarketBeat·2mo ago
News Placeholder
Aldeyra Therapeutics Target of Unusually Large Options Trading (NASDAQ:ALDX)
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX - Get Free Report) saw some unusual options trading activity on Tuesday. Investors bought 12,807 call options on the stock. This is an increase of 1,592...
MarketBeat·2mo ago
News Placeholder
Why Is Aldeyra Therapeutics Stock Surging After FDA Delayed Its Dry Eye Drug Decision?
The FDA delayed its decision on the dry eye drug Reproxalap to March 2026 without raising new issues, while review and labeling discussions continued.
Stocktwits·2mo ago
News Placeholder
683 Capital Management LLC Has $4.14 Million Stake in Aldeyra Therapeutics, Inc. $ALDX
683 Capital Management LLC grew its position in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX - Free Report) by 126.9% during the second quarter, according to the company in its most recent 13F filing with...
MarketBeat·2mo ago
News Placeholder
Aldeyra Therapeutics, Inc. $ALDX Shares Sold by Kennedy Capital Management LLC
Kennedy Capital Management LLC lessened its position in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX - Free Report) by 44.3% in the second quarter, according to the company in its most recent Form 13F...
MarketBeat·2mo ago
<
1
2
...
>

Latest ALDX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.